To the full analysis
Buyback calculator for Vicore Pharma Holding
Vicore Pharma Holding stock: key metrics
VICO.STVicore Pharma Holding had an operating margin of −11,905.8% and a return on invested capital (ROIC) of −32.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2012 | 10.2% | −53.7% | −95.3% |
| 2013 | 121.8% | −90.6% | −48.5% |
| 2014 | 145.8% | −339.9% | 871.2% |
| 2015 | 197.1% | −540.8% | −544.0% |
| 2016 | 243.3% | −780.4% | −780.8% |
| 2017 | 383.8% | −1,372.6% | −1,379.3% |
| 2018 | −4,182.7% | −8,716.5% | −4,267.9% |
| 2019 | no data | no data | no data |
| 2020 | no data | no data | no data |
| 2021 | no data | no data | no data |
| 2022 | no data | no data | no data |
| 2023 | no data | no data | no data |
| 2024 | 100.0% | −177.6% | −154.2% |
| 2025 | 100.0% | −11,905.8% | −12,509.1% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2012 | −12.0% | −6.2% | −8.2% |
| 2013 | −4.0% | −14.3% | −3.1% |
| 2014 | 25.5% | −6.2% | 23.1% |
| 2015 | −5.6% | −6.5% | −5.1% |
| 2016 | −8.8% | −8.2% | −8.1% |
| 2017 | −11.4% | −12.6% | −10.8% |
| 2018 | −7.6% | −46.7% | −7.2% |
| 2019 | −28.9% | −24.3% | −27.3% |
| 2020 | −41.4% | −34.6% | −36.1% |
| 2021 | −77.3% | −62.6% | −65.7% |
| 2022 | −99.8% | −67.8% | −85.3% |
| 2023 | −68.3% | −67.9% | −62.5% |
| 2024 | −14.9% | −19.3% | −14.0% |
| 2025 | −43.6% | −32.2% | −39.1% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Dec 2016)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.